USD 14.85 billion
Report ID:
SQMIG30A2012 |
Region:
Global |
Published Date: November, 2024
Pages:
165
|Tables:
97
|Figures:
76
Clinical Nutrition Market size was valued at USD 38.7 Billion in 2023 and is poised to grow from USD 41.76 Billion in 2024 to USD 76.72 Billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).
A clinical nutrition product helps the metabolic system work better by giving the body what it needs, like minerals, vitamins, and other nutrients that improve patients’ health. Clinical nutrition is the study and treatment of diseases that affect food intake, digestion, and metabolism. It also aims to improve health by preventing diseases that are caused by eating habits. It is used in many situations, such as cardiac rehabilitation, renal dialysis, diabetes, pediatrics, nutrition support, cancer, trauma, wellness centers, and community-based intervention programs.
As lifestyle-related diseases like inflammatory bowel disease and diabetes rise, so does the number of people who need clinical nutrition. An increasing number of older people and government investments in research and development in the health care sector also help the clinical nutrition market growth. Also, growing demand for clinical nutrition in emerging markets like Asia-Pacific and Latin America and a rise in the use of nutritional products in-home care are likely to make the global clinical nutrition market an attractive investment destination during the analysis period.
US Clinical Nutrition Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 14.85 billion
Largest Segment
Pediatric
Fastest Growth
Pediatric
Growth Rate
5% CAGR
To get more reports on the above market click here to Buy The Report
Global Clinical Nutrition Market is segmented by Route of Administration, application, Distribution Channel, end user, Nutritional Content and region. Based on Route of Administration, the market is segmented into Oral, Parenteral, and Enteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorder, Metabolic Disorder, and Others. Based on Distribution Channel, the market is segmented into Online and Offline. Based on end user, the market is segmented into Paediatric, Adults, and Geriatric. Based on By Nutritional Content, the market is segmented into Protein-Based Nutrition, Vitamin and Mineral-Rich Nutrition, Carbohydrate-Based Nutrition, and Fat-Based Nutrition. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Clinical Nutrition Market Analysis by Route of Administration
In 2023, the oral nutrition segment captured the largest revenue share at 53.29%. The market growth is driven by the rising prevalence of malnutrition among adults and the increasing instances of obesity and chronic diseases like cancer and diabetes. Leading companies and innovators are focused on launching novel products to boost productivity, durability, quality, and nutritional value of food products. In addition to enhancing nutritional content, clinical nutrition manufacturers are striving to improve product taste by incorporating various flavors. These efforts are significantly contributing to market expansion.
The parenteral nutrition segment is projected to experience the fastest CAGR during the forecast period. This growth is fueled by the development of advanced parenteral nutrition (PN) products with barcode assistance, an increasing preference for PN over enteral nutrition among patients, shorter hospital stays, and a reduced risk of infection. These factors are driving the demand for PN products, consequently propelling market growth.
Clinical Nutrition Market Analysis by Application
In 2023, the cancer care segment accounted for 15.13% of global revenue, primarily due to the rising prevalence of cancer. With global cancer cases projected to reach 30 million by 2040, especially in low- and middle-income countries, addressing this growing burden is crucial. Cancer often leads to malnutrition in 40% to 80% of cases, making clinical nutrition like tube feeding essential for maintaining nutrition and improving treatment outcomes.
The Malabsorption/GI Disorder/Diarrhea segment is projected to grow at the fastest CAGR during the forecast period. Malabsorption refers to the difficulty in digesting nutrients from food, caused by conditions like short bowel syndrome, cystic fibrosis, chronic pancreatitis, and Crohn’s disease. This can lead to other health issues if the body lacks proper nutrients. Enteral nutrition, through oral or tube feeding, is crucial in these cases as it supplies essential nutrients and enhances gut immunity. Various enteral feeds, such as Abbott's Vital Peptide 1.5 Cal, offer therapeutic formulations beneficial for treating malabsorption and gastrointestinal disorders.
To get detailed analysis on other segments, Request For Free Sample Report
In 2021, North America accounts for the largest share of the market and is expected to register a CAGR of 5.5% during the projected period. Continuous clinical nutrition R&D is a key trend in the clinical nutrition sector in North America. In addition, for several chronic diseases, including coronary artery disease, ischemic stroke, diabetes, and a few cancer indications. Diabetes prevalence has boosted the demand for medical nutrition therapy. In addition, the expanding demand for clinical nutrition in the pediatric sector is likely to present market participants with lucrative growth opportunities and drive the clinical nutrition market size during the analysis period.
Asia-Pacific has the highest growth rate. Significant factors contributing to the growth of the Asia Pacific clinical nutrition market include an increase in the frequency of metabolic disorders and neurological diseases, a rise in the geriatric population in the region, and high healthcare expenditure. In addition, increasing government initiatives for the improvement of the healthcare industry and a rise in the emphasis of leading manufacturers on expanding their geographic presence in emerging nations to capture high growth opportunities in the market are driving the clinical nutrition market's growth.
Europe accounts for the second largest market for clinical nutrition market in the year 2021. The clinical nutrition market in Europe is anticipated to grow at a CAGR of 6.2% during the forecast period. The alarming increase in nutrition therapy and dietary therapy for patients with metabolic syndrome is a major factor driving the clinical nutrition market in this region. In addition, raising patient knowledge regarding the availability of clinical nutrition in European nations is predicted to enhance market growth. In addition, an increase in government support for innovation and an increase in the funding of initiatives for new clinical nutrition research and development fuel the clinical nutrition market growth in this region during the forecast period.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Clinical Nutrition Market Driver
Rising incidences of lifestyle-associated diseases and a growing geriatric population are driving the market.
Clinical Nutrition Market Restraint
Lack of awareness of clinical nutrition and high costs are some of the major restraints.
Request Free Customization of this report to help us to meet your business objectives.
The clinical nutrition market is relatively fragmented, with a high level of competition. Few large players, like Glanbia Plc, Pfizer Inc., and Danone Nutricia, now control the market in terms of market share. These industry leaders are extending their customer base across several areas, and many corporations are creating strategic and collaborative initiatives with other start-up enterprises to enhance their market share and profitability.
Clinical Nutrition Market Top Player’s Company Profiles
Clinical Nutrition Market Recent Developments
In January 2024, Hologram Sciences, a prominent figure in health technology and personalized nutrition, announced a collaboration with Mayo Clinic to develop the 'Precision Nutrition Platform'. This innovative initiative harnesses advanced machine learning and adaptive technologies, integrating clinical insights from Mayo Clinic through a know-how agreement. The primary objective is to tackle the prevalent challenges of malnutrition in surgical recovery while simultaneously elevating patient care across various disciplines.
In January 2024, Danone announced a strategic partnership with Resilience, a digital oncology company, aimed at enhancing nutritional care for patients battling cancer.
In May 2022, Abbott announced that the U.S. District Court for the Western District of Michigan had revised the recent consent decree, permitting Abbott to release limited amounts of its EleCare specialized amino acid-based products. Abbott and the FDA asked for the consent agreement to be changed so EleCare may be given to sick children.
In May 2022, Glanbia Nutritionals announced that it has acquired Sterling Technology a major provider of dairy bioactive solutions produced from bovine colostrum to enhance its bioactive solutions portfolio to support customers’ needs and growth.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, in 2021, the gastrointestinal disorders segment accounted for the largest market share and is predicted to grow at more than 5.6% CAGR during the analysis period. An increasing number of older people and government investments in research and development in the health care sector also help the clinical nutrition market growth. Growing demand for clinical nutrition in emerging markets like Asia-Pacific and Latin America and a rise in the use of nutritional products in-home care are some of the major factors that will increase the market size over the projection period. In 2021, North America accounts for the largest share of the market and is expected to register a CAGR of 5.5% during the projected period. People suffering from chronic diseases such as cancer and diabetes, as well as the aging population, are expected to contribute to clinical nutrition market growth throughout the analysis period. Continuous clinical nutrition R&D is a key trend in the clinical nutrition sector in North America.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 35.6 billion |
Market size value in 2031 | USD 71.1 billion |
Growth Rate | 7.9% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Clinical Nutrition Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Clinical Nutrition Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Clinical Nutrition Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Clinical Nutrition Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG30A2012
sales@skyquestt.com
USA +1 351-333-4748